Mineralys (MLYS) CMO exercises options and sells 2,170 shares under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Mineralys Therapeutics, Inc. Chief Medical Officer David Malcom Rodman exercised stock options for 2,170 shares of common stock at $16.00 per share and then sold 2,170 shares in an open-market transaction at $27.38 per share.
These transactions were made under a pre-arranged Rule 10b5-1 trading plan adopted on October 6, 2025. Following the sale, he directly holds 76,140 shares of Mineralys Therapeutics common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 2,170 shares ($59,415)
Net Sell
3 txns
Insider
Rodman David Malcom
Role
Chief Medical Officer
Sold
2,170 shs ($59K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 2,170 | $0.00 | -- |
| Exercise | Common Stock | 2,170 | $16.00 | $35K |
| Sale | Common Stock | 2,170 | $27.38 | $59K |
Holdings After Transaction:
Stock Option — 21,706 shares (Direct);
Common Stock — 78,310 shares (Direct)
Footnotes (1)
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025. The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter.
Key Figures
Options exercised: 2,170 shares
Exercise price: $16.00 per share
Shares sold: 2,170 shares
+4 more
7 metrics
Options exercised
2,170 shares
Stock option exercise into common stock
Exercise price
$16.00 per share
Stock option exercise price
Shares sold
2,170 shares
Open-market sale of common stock
Sale price
$27.38 per share
Price for open-market sale
Post-sale holdings
76,140 shares
Common stock held directly after transactions
Option expiration
February 9, 2033
Expiration date of exercised stock option
10b5-1 adoption date
October 6, 2025
Adoption date of Rule 10b5-1 trading plan
Key Terms
Stock Option, Rule 10b5-1 trading plan, open-market sale, exercise price, +1 more
5 terms
Stock Option financial
"The insider held a Stock Option that was exercised for 2,170 shares."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Rule 10b5-1 trading plan regulatory
"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
open-market sale financial
"The filing describes the transaction as an open-market sale of 2,170 common shares."
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
exercise price financial
"The stock option carried a $16.00 exercise price per share."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
derivative security financial
"The Form 4 notes an Exercise or conversion of derivative security for the stock option."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
What insider transactions did Mineralys Therapeutics (MLYS) report for David Malcom Rodman?
Mineralys Therapeutics reported that Chief Medical Officer David Malcom Rodman exercised options for 2,170 shares at $16.00 and sold 2,170 common shares at $27.38. These moves combined an option exercise with an immediate open-market sale on the same date.
Was the Mineralys Therapeutics (MLYS) insider trade under a Rule 10b5-1 plan?
Yes. The filing states the transactions were effected under a Rule 10b5-1 trading plan adopted on October 6, 2025. Such plans pre-schedule trades, indicating the timing of this exercise-and-sale sequence was predetermined rather than a spontaneous market-timing decision.
What type of derivative security did the Mineralys Therapeutics (MLYS) insider exercise?
The insider exercised a stock option covering 2,170 underlying shares of Mineralys Therapeutics common stock with a $16.00 exercise price and a February 9, 2033 expiration date. Exercising converted the option into common shares, which were then sold in the market.